Phase 3 Readout~month

Phase 3 Topline: A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus PFS in Subjects With Visual Impair

Drug
visual
Indication
Age-Related Macular Degeneration; Neovascular Age-related Macular Degeneration; Wet Macular Degeneration

Other upcoming events for OTLK

Phase 3 ReadoutPhase 3 Topline: A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus PFS in Subjects With Visual Impair

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus PFS in Subjects With Visual Impair — OTLK Phase 3 Readout | BioSniper